{
  "actions": [
    {
      "acted_at": "2025-05-21",
      "action_code": "Intro-H",
      "references": [],
      "text": "Introduced in House",
      "type": "action"
    },
    {
      "acted_at": "2025-05-21",
      "action_code": "H11100",
      "committees": [
        "HSIF"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    },
    {
      "acted_at": "2025-05-21",
      "action_code": "H11100",
      "committees": [
        "HSJU"
      ],
      "references": [],
      "text": "Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "hr3546-119",
  "bill_type": "hr",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "House Judiciary",
      "committee_id": "HSJU"
    },
    {
      "activity": [
        "Referred To"
      ],
      "committee": "House Energy and Commerce",
      "committee_id": "HSIF"
    }
  ],
  "congress": "119",
  "cosponsors": [
    {
      "bioguide_id": "A000381",
      "district": "3",
      "name": "Ansari, Yassamin",
      "original_cosponsor": false,
      "sponsored_at": "2025-07-22",
      "state": "AZ",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "J000298",
      "district": "7",
      "name": "Jayapal, Pramila",
      "original_cosponsor": false,
      "sponsored_at": "2025-05-23",
      "state": "WA",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "O000173",
      "district": "5",
      "name": "Omar, Ilhan",
      "original_cosponsor": false,
      "sponsored_at": "2025-06-03",
      "state": "MN",
      "title": "Rep.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "S001145",
      "district": "9",
      "name": "Schakowsky, Janice D.",
      "original_cosponsor": true,
      "sponsored_at": "2025-05-21",
      "state": "IL",
      "title": "Rep.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2025-05-21",
  "number": "3546",
  "official_title": "To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.",
  "popular_title": null,
  "related_bills": [
    {
      "bill_id": "s1818-119",
      "identified_by": "CRS",
      "reason": "identical",
      "type": "bill"
    }
  ],
  "short_title": "Prescription Drug Price Relief Act of 2025",
  "sponsor": {
    "bioguide_id": "K000389",
    "district": "17",
    "name": "Khanna, Ro",
    "state": "CA",
    "title": "Rep.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2025-05-21",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": null,
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Prescription Drug Price Relief Act of 2025",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Prescription Drug Price Relief Act of 2025",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "To significantly lower prescription drug prices for patients in the United States by ending government-granted monopolies for manufacturers who charge drug prices that are higher than the median prices at which the drugs are available in other countries.",
      "type": "official"
    }
  ],
  "updated_at": "2025-11-18T18:26:33Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/119/hr/BILLSTATUS-119hr3546.xml"
}